Development and external validation of a novel prognostic nomogram for overall survival in prostate cancer patients with bone metastatic: a retrospective study of the SEER-based and a single Chinese center-Reference-Cited by-同舟云学术

Development and external validation of a novel prognostic nomogram for overall survival in prostate cancer patients with bone metastatic: a retrospective study of the SEER-based and a single Chinese center

Published:2023-07-14 Issue:14 Volume:149 Page:12647-12658
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Zhang Hongyu,Jiang Xinzhan,Jiao Le,Sui Meiyan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-05126-x.pdf

Reference27 articles.

1. Alba AC, Agoritsas T, Walsh M et al (2017) Discrimination and calibration of clinical prediction models: users’ guides to the medical literature. JAMA 318:1377–1384. https://doi.org/10.1001/jama.2017.12126

2. Antonarakis ES, Tagawa ST, Galletti G et al (2017) Randomized, noncomparative, phase II trial of early switch from docetaxel to cabazitaxel or vice versa, with integrated biomarker analysis, in men with chemotherapy-naïve, metastatic, castration-resistant prostate cancer. J Clin Oncol 35:3181–3188. https://doi.org/10.1200/JCO.2017.72.4138

3. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492

4. Chen S, Wang L, Qian K et al (2019) Establishing a prediction model for prostate cancer bone metastasis. Int J Biol Sci 15:208–220. https://doi.org/10.7150/ijbs.27537

5. Chin SP, Dickinson JL, Holloway AF (2011) Epigenetic regulation of prostate cancer. Clin Epigenetics 2:151–169. https://doi.org/10.1007/s13148-011-0041-7